Can Endometriosis Cause Cancer? Risk and Care Options

Endometriosis does not usually turn into cancer, and most people with endometriosis will never develop a related cancer. However, it is associated with a small increased risk of certain ovarian cancer types, making appropriate evaluation of new or changing symptoms important.

Can endometriosis cause cancer?

Endometriosis is not cancer. It is a chronic condition in which tissue similar to the lining of the uterus grows outside the uterus, commonly on the ovaries, fallopian tubes, pelvic lining, bowel, or bladder. These growths can cause inflammation, pain, scar tissue, and fertility difficulties, but they are usually benign.

In uncommon cases, cancer can develop in areas affected by endometriosis, most often in an ovarian endometrioma, sometimes called a chocolate cyst. Research shows a small increase in the likelihood of certain ovarian cancers among people with endometriosis. The overall chance remains low, and this association does not mean that endometriosis will become cancer.

It is also important not to confuse endometriosis with endometrial cancer. Endometrial cancer begins in the lining of the uterus, whereas endometriosis involves endometrial-like tissue growing outside the uterus. The two conditions have different symptoms, risk factors, diagnostic pathways, and treatments.

• Most endometriosis lesions remain noncancerous.
• Persistent symptoms deserve medical review even in people with a known diagnosis.
• Individual risk depends on age, family history, imaging findings, and other health factors.

Does endometriosis increase cancer risk?

Yes, endometriosis is associated with a modestly increased risk of particular ovarian cancer subtypes, including clear cell and endometrioid ovarian cancer. These cancers are still uncommon, including among people with endometriosis. For most patients, the more immediate effects of endometriosis are pelvic pain, painful periods, pain during sex, bowel or bladder symptoms around menstruation, and challenges with fertility.

The reasons for the association are not fully understood. Long-standing inflammation, hormonal influences, and genetic changes within some endometriosis lesions may play a role. Having an ovarian endometrioma, especially one that is large, persists after menopause, or develops unusual features on imaging, may lead a clinician to recommend more detailed assessment.

Risk assessment should be individualized. A strong family history of ovarian, breast, pancreatic, prostate, or colorectal cancer may warrant discussion of inherited cancer syndromes and genetic counseling. A gynecologist can help distinguish symptoms from endometriosis from signs that need separate investigation.

Routine ovarian cancer screening with blood tests or ultrasound is not recommended for everyone with endometriosis because these tests have limitations and can lead to unnecessary procedures. Instead, clinicians use symptoms, examination findings, and imaging when there is a specific concern.

Symptoms and diagnosis: when further evaluation is needed

Endometriosis symptoms can overlap with symptoms of ovarian, uterine, bowel, and bladder conditions. This does not mean that cancer is likely, but it does mean that new symptoms should not automatically be attributed to a previous diagnosis. A clinician may ask about the timing, severity, and progression of symptoms, menstrual changes, medication use, pregnancy plans, and family history.

Possible assessments include a pelvic examination, transvaginal or abdominal ultrasound, and magnetic resonance imaging in selected situations. Imaging can help identify cysts, fibroids, masses, or features suggesting deep endometriosis, although it cannot always confirm the diagnosis. Laparoscopy with tissue sampling may be recommended when surgery is needed for symptoms, an uncertain mass, or treatment planning.

If cancer is suspected, doctors may use additional imaging, laboratory tests, and biopsy or surgical pathology to establish an accurate diagnosis. A diagnosis should not be based on a tumor marker alone, as several noncancerous conditions, including endometriosis, can affect some blood test results.

Clear communication about prior scans, surgeries, pathology reports, and changing symptoms can help the care team make informed decisions. Patients are encouraged to ask why a test is being recommended and what the next steps may be for different possible results.

Does caffeine make endometriosis worse?

There is no clear evidence that caffeine directly causes endometriosis or consistently makes it worse for every person. Studies of caffeine, coffee, and endometriosis symptoms have produced mixed findings. Some people notice that coffee, tea, energy drinks, or cola worsen bloating, breast tenderness, anxiety, sleep problems, or pelvic discomfort, while others notice no meaningful change.

A practical approach is to pay attention to individual patterns. Keeping a brief diary of meals, caffeinated drinks, menstrual timing, pain, bowel symptoms, and sleep may reveal whether caffeine seems to trigger symptoms. If it does, reducing intake gradually or choosing decaffeinated alternatives can be reasonable.

Dietary changes should support, rather than replace, medical care. Regular meals, adequate fluids, movement suited to the person’s comfort, sleep support, and stress-management strategies may help overall well-being. A registered dietitian can offer individualized advice, particularly for people with bowel symptoms, dietary restrictions, or fertility concerns.

Does tamoxifen make endometriosis worse?

Tamoxifen is a selective estrogen receptor modulator commonly used in the treatment or prevention of certain hormone receptor-positive breast cancers. Its effects differ by tissue: it blocks estrogen activity in breast tissue but can have estrogen-like effects in the uterus. This may be relevant for people with a history of endometriosis.

There have been reports of endometriosis developing or becoming symptomatic during tamoxifen treatment, particularly in postmenopausal patients, but this is not a predictable outcome for every person. Tamoxifen can also affect the uterine lining, which is why unexpected vaginal bleeding while taking it requires prompt medical assessment.

No patient should stop tamoxifen because of pelvic symptoms without consulting the oncology team. The clinician may arrange a gynecologic evaluation, imaging, or other tests as appropriate and will balance symptom management with the important benefits tamoxifen may provide for breast cancer care.

How successful is treatment for endometrial cancer?

Endometrial cancer is a cancer of the uterine lining and is distinct from endometriosis. Treatment is often successful, especially when the cancer is found before it has spread beyond the uterus. Many cases are identified early because abnormal vaginal bleeding, particularly bleeding after menopause, prompts evaluation.

Care is tailored to the cancer’s stage, grade, cell type, molecular features, and the patient’s overall health and reproductive wishes. Surgery to remove the uterus, and often the fallopian tubes and ovaries, is a common first treatment. Depending on the individual situation, treatment may also include radiation therapy, chemotherapy, hormone therapy, targeted therapy, or immunotherapy.

Outlook cannot be predicted from one feature alone. Earlier-stage, lower-grade cancers generally have more favorable outcomes than cancers that have spread or have high-risk biological features. A gynecologic oncologist can explain pathology findings, treatment goals, follow-up plans, and possible effects on fertility, menopause, and quality of life.

People with abnormal uterine bleeding should seek assessment promptly. This includes bleeding after menopause, bleeding between periods, unusually heavy or prolonged periods, or a significant change in an established bleeding pattern.

Modern treatment approaches for endometriosis

Endometriosis care is individualized. Treatment aims may include reducing pain, improving daily function, preserving or supporting fertility, treating ovarian cysts or deep disease, and addressing emotional well-being. A person’s symptoms, imaging findings, age, medical history, and pregnancy plans all influence the best approach.

Common options include anti-inflammatory pain medicines when appropriate, hormonal treatments that reduce menstrual activity, and surgery for selected patients. Hormonal treatment may include combined hormonal contraceptives, progestin-based options, or medicines that temporarily lower estrogen activity. Surgical treatment may remove endometriosis lesions, scar tissue, or endometriomas, and can be particularly useful when pain persists despite medication, anatomy is affected, or diagnosis is uncertain.

For patients considering surgery, laparoscopic surgery may allow a surgeon to assess and treat pelvic disease through small incisions. Fertility support can include timed attempts at conception, fertility evaluation, surgery in selected situations, or in vitro fertilization treatment when appropriate. Recurrence of symptoms can occur, so follow-up and longer-term planning are important.

Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals provide diagnostic assessment and treatment planning for international patients with endometriosis and related gynecologic concerns.

When to seek medical care

A planned gynecology appointment is appropriate for pelvic pain that interferes with daily life, painful periods that are worsening, pain during sex, infertility concerns, recurrent ovarian cysts, or symptoms that do not improve with an agreed treatment plan. Review is also sensible when symptoms change after menopause or after starting a new hormonal medicine.

Medical care should be sought promptly for new abdominal or pelvic swelling, persistent bloating, feeling full unusually quickly, unexplained weight changes, worsening pelvic pressure, a newly felt pelvic mass, or unusual vaginal bleeding. These symptoms are common and often have noncancerous explanations, but assessment helps identify the cause.

Urgent evaluation is needed for severe sudden pelvic or abdominal pain, fainting, fever with pelvic pain, heavy bleeding, or symptoms of severe illness. These may indicate complications such as cyst rupture, ovarian torsion, infection, or another urgent condition rather than cancer.

Frequently asked questions